Departamento de Enfermería, Universidad Católica "San Antonio" de Murcia, Murcia, Andalucía, Spain.
Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Neurourol Urodyn. 2018 Nov;37(8):2702-2709. doi: 10.1002/nau.23723. Epub 2018 Jul 4.
To evaluate the prevalence, distress, and impact of pelvic floor dysfunction (PFD) symptomatology in women with fibromyalgia and control women. We also aimed to evaluate the impact of PFD symptomatology on several psychosocial measures such as mood, sleep, pain, and quality of life.
We conducted a cross-sectional study in women with fibromyalgia and control women from the general population. Using a structured survey, we collected sociodemographic and clinical data, assessed the prevalence of PFD and evaluated the distress (PFDI-20) and the impact (PFIQ-7) caused by its symptomatology. Using Spanish-validated questionnaires, we also evaluated mood and sleep disturbances, bodily pain, and quality of life in subjects with and without PFD. In participants with fibromyalgia, we assessed the severity and impact of the disease using the Fibromyalgia Impact Questionnaire (FIQR).
Two hundred and twenty-six patients with fibromyalgia and 222 control women completed the surveys. Two hundred and twenty patients (93%) and 140 controls (63%) reported PFD-related symptoms. Both the scores of distress (143.1 ± 5.7 vs 96.1 ± 4.8, P < 0.0001) and impact (122.4 ± 5.6 vs 100.6 ± 6.4, P < 0.0001) caused by PFD symptoms were significantly higher in women with fibromyalgia than in controls. There was a significant positive relationship between fibromyalgia severity and both PFDI-20 (r = 0.32, P < 0.0001) and PFIQ-7 scores (r = 0.375, P < 0.0001). Depression severity, sleep disturbances, bodily pain, and low quality of life were highest in women with fibromyalgia and PFD and lowest in control women without PFD.
PFD-related symptoms were significantly more frequent in women with fibromyalgia than in controls. PFD symptomatology, when present, negatively influenced mood, sleep quality, and quality of life of both patients with fibromyalgia and controls.
评估患有纤维肌痛症的女性和对照组女性中盆底功能障碍（PFD）症状的患病率、痛苦程度和影响。我们还旨在评估 PFD 症状对一些心理社会措施的影响，如情绪、睡眠、疼痛和生活质量。
我们对纤维肌痛症患者和来自普通人群的对照组女性进行了横断面研究。使用结构化调查，我们收集了社会人口统计学和临床数据，评估了 PFD 的患病率，并评估了其症状引起的痛苦（PFDI-20）和影响（PFIQ-7）。使用经过西班牙验证的问卷，我们还评估了有和没有 PFD 的受试者的情绪和睡眠障碍、身体疼痛和生活质量。在纤维肌痛症患者中，我们使用纤维肌痛影响问卷（FIQR）评估了疾病的严重程度和影响。
226 名纤维肌痛症患者和 222 名对照组女性完成了调查。220 名（93%）患者和 140 名（63%）对照组女性报告了与 PFD 相关的症状。纤维肌痛症患者的 PFD 症状引起的痛苦（143.1±5.7 比 96.1±4.8，P<0.0001）和影响（122.4±5.6 比 100.6±6.4，P<0.0001）评分均显著高于对照组女性。纤维肌痛症的严重程度与 PFDI-20（r=0.32，P<0.0001）和 PFIQ-7 评分（r=0.375，P<0.0001）均呈显著正相关。纤维肌痛症和 PFD 患者的抑郁严重程度、睡眠障碍、身体疼痛和生活质量最低，而对照组女性无 PFD 的则最高。
患有纤维肌痛症的女性中 PFD 相关症状的发生率明显高于对照组女性。PFD 症状的存在对纤维肌痛症患者和对照组女性的情绪、睡眠质量和生活质量产生负面影响。
